Alirocumab Subcutaneous Injection Generics - Manufacturers & Suppliers

Praluent(US & EU)

Product/Composition:- Alirocumab Subcutaneous Injection
Strength:- 75 mg/mL and 150 mg/mL
Form:- Subcutaneous Injection
Reference Brands:- Praluent(US & EU)
MOQ As per the manufacturer batch size
Get Quote Send Enquiry on WhatsApp

Alirocumab is a monoclonal antibody that inhibits PCSK9, increasing LDL receptor availability to enhance LDL cholesterol clearance from the blood. It effectively lowers LDL levels, reducing cardiovascular risk. Benefits include significant LDL reductions, improved heart health, and prevention of atherosclerotic events in high-risk patients.

Alirocumab, marketed as Praluent, is approved in the US by the FDA and in the EU via EMA for lowering LDL cholesterol in patients with familial hypercholesterolemia or cardiovascular risk. Regulatory approval requires a comprehensive dossier including clinical trial data, safety profiles, manufacturing standards, and pharmacovigilance plans. The FDA reviews detailed clinical and quality data to ensure safety and efficacy, while the EMA evaluates regional safety and manufacturing compliance. For guidance on dossier preparation, regulatory pathways, and market access, visit PharmaTradz. Ensuring regulatory adherence supports timely approval, safe use, and global availability of alirocumab subcutaneous injections, contributing to improved cardiovascular health worldwide.

Pharmatradz Quality Assurance

In order to maintain the quality requirements, We evaluate every manufactuer businesses before they join pharmatradz platform. Alirocumab Subcutaneous Injection manufacturers & Suppliers must meet the required criteria in addition to their good manufacturing practice certifications. This enables us to scrutinise Alirocumab Subcutaneous Injection manufacturers for the calibre of the pharmaceutical products and guard against the possibility of potential misconduct.

After completing the free registration process and joining our online marketplace, pharmaceutical licencing businesses or distributors can negotiate offers with Alirocumab Subcutaneous Injection manufacturing companies. By doing so, you can avoid the time-consuming sourcing, negotiating, and ordering processes and ensure that the pharmaceutical deal is completed at a fair price while also achieving the optimum cost-benefit ratio for your business.

Building Stronger Commercial Ties

By using our marketplace, You can expect a sustained business relationship with Alirocumab Subcutaneous Injection manufacturers and suppliers. Pharmatradz marketplace lets you as a buyer skip the Alirocumab Subcutaneous Injection manufacturers pre-screening process every time you're searching for in-licensing or distribution deals.

Third Party / Contract Manufacturing

PharmaTradz offers Whitelabelling of Pharmacy finished products from GMP Facilties as per regulatory requirments of sourcing country with complete documentation , dossier support , Direct or registration supplies. Pharmatradz assists in finding qualified third party /contract manufacturers and suppliers for Alirocumab Subcutaneous Injection. This provides huge cost savings for your business and ensures your business start-up is hassle-free. During this process, an agreement is signed between the client and the Alirocumab Subcutaneous Injection manufacturers, and the manufacturing company makes product as per the contract.

Find Alirocumab Subcutaneous Injection Manufacturers & Suppliers

At Pharmatradz, we help you in finding qualified & verified Alirocumab Subcutaneous Injection manufacturers or Alirocumab Subcutaneous Injection suppliers from our global list of sellers. For more information about sourcing wholesale supplies of Alirocumab Subcutaneous Injection, please speak to one of Pharmatradz's representatives on +91 800030 4400 or send an email to bd@pharmatradz.com. We will get back to you as soon as possible.

Popular & High Demand Pharma Products

Corporate Ads
POST ENQUIRY Looking for a Supplier?